| Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia CM McMahon, T Ferng, J Canaani, ES Wang, JJD Morrissette, ... Cancer discovery 9 (8), 1050-1063, 2019 | 381 | 2019 |
| FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation T Itkin, A Ludin, B Gradus, S Gur-Cohen, A Kalinkovich, A Schajnovitz, ... Blood, The Journal of the American Society of Hematology 120 (9), 1843-1855, 2012 | 122 | 2012 |
| Egress and mobilization of hematopoietic stem and progenitor cells: a dynamic multi-facet process K Lapid, C Glait-Santar, S Gur-Cohen, J Canaani, O Kollet, T Lapidot | 97 | 2013 |
| MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease N Maharshak, S Shenhar-Tsarfaty, N Aroyo, N Orpaz, I Guberman, ... Inflammatory bowel diseases 19 (7), 1346-1353, 2013 | 82 | 2013 |
| Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute … A Nagler, M Labopin, M Houhou, M Aljurf, A Mousavi, RM Hamladji, ... Journal of Hematology & Oncology 14, 1-12, 2021 | 75 | 2021 |
| Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation J Canaani, BN Savani, M Labopin, XJ Huang, F Ciceri, W Arcese, Y Koc, ... American journal of hematology 93 (2), 246-253, 2018 | 75 | 2018 |
| Outcome of allogeneic hematopoietic stem cell transplantation in patients age> 69 years with acute myelogenous leukemia: on behalf of the Acute Leukemia Working Party of the … O Ringdén, A Boumendil, M Labopin, J Canaani, D Beelen, G Ehninger, ... Biology of Blood and Marrow Transplantation 25 (10), 1975-1983, 2019 | 74 | 2019 |
| Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia CM McMahon, J Canaani, B Rea, RL Sargent, JN Qualtieri, CD Watt, ... Blood Advances 3 (10), 1581-1585, 2019 | 72 | 2019 |
| Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors O Kollet, Y Vagima, G D'uva, K Golan, J Canaani, T Itkin, S Gur-Cohen, ... Leukemia 27 (10), 2006-2015, 2013 | 67 | 2013 |
| Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete … S Giebel, M Labopin, M Potter, X Poiré, H Sengeloev, G Socié, A Huynh, ... European journal of cancer 96, 73-81, 2018 | 64 | 2018 |
| Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the Acute Leukemia … J Canaani, BN Savani, M Labopin, X Huang, F Ciceri, W Arcese, J Tischer, ... haematologica 102 (6), 1066, 2017 | 53 | 2017 |
| Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin S Ben-Baruch, J Canaani, R Braunstein, C Perry, J Ben-Ezra, A Polliack, ... Mayo Clinic Proceedings 87 (2), 136-142, 2012 | 50 | 2012 |
| Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: a … S Eder, J Canaani, E Beohou, M Labopin, J Sanz, W Arcese, R Or, J Finke, ... American journal of hematology 92 (10), 997-1003, 2017 | 48 | 2017 |
| Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis J Canaani, E Beohou, M Labopin, A Ghavamzadeh, D Beelen, ... Journal of internal medicine 285 (4), 407-418, 2019 | 41 | 2019 |
| Comparison of haploidentical bone marrow versus matched unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute … A Nagler, M Labopin, B Dholaria, E Angelucci, B Afanasyev, ... Clinical Cancer Research 27 (3), 843-851, 2021 | 36 | 2021 |
| Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute … J Canaani, M Labopin, XJ Huang, F Ciceri, MT Van Lint, B Bruno, ... British journal of haematology 183 (3), 411-420, 2018 | 34 | 2018 |
| Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR 1: An … J Canaani, E Beohou, M Labopin, G Socie, A Huynh, L Volin, ... American journal of hematology 92 (4), 344-350, 2017 | 34 | 2017 |
| Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia J Canaani, M Labopin, M Itälä-Remes, D Blaise, G Socié, E Forcade, ... Leukemia 33 (8), 1944-1952, 2019 | 29 | 2019 |
| Mechanisms of acquired resistance to gilteritinib therapy in relapsed and refractory FLT3-mutated acute myeloid leukemia CM McMahon, J Canaani, B Rea, RL Sargent, JJD Morrissette, ... Blood 130, 295, 2017 | 29 | 2017 |
| Regulatory cross talks of bone cells, hematopoietic stem cells and the nervous system maintain hematopoiesis O Kollet, J Canaani, A Kalinkovich, T Lapidot Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2012 | 29 | 2012 |
